NCC MEDICAL GROUP is a recognized leader in the development and manufacturing of advanced neuro-diagnostic technologies and surgical medical consumables. Since its establishment in 1997, the company has focused on delivering innovative solutions that enhance surgical safety, diagnostic accuracy, and patient care quality across global healthcare systems.
As a designated National SRDI “Little Giant” Enterprise, NCC is recognized for its specialized technological capabilities, refined manufacturing processes, distinctive innovation capacity, and continuous research advancement. The SRDI designation represents a prestigious national recognition given to companies with strong proprietary technologies and significant contributions to industrial innovation.
NCC’s research and manufacturing operations are headquartered in Shanghai, China, one of the world’s leading centers for medical technology development. The Shanghai facilities focus on cutting-edge neurophysiology research, precision engineering, and the large-scale production of medical devices and consumables used in neurology and surgical monitoring.
To ensure international quality compliance and regulatory alignment, NCC operates a global quality and regulatory coordination center in Singapore. This facility manages international certification processes, regulatory documentation, and global quality assurance programs, enabling NCC products to meet the requirements of healthcare markets across multiple continents.
The company specializes in several key technology areas including IONM (Intraoperative Neuromonitoring), EEG (Electroencephalography), PSG (Polysomnography), and EMG (Electromyography) systems. These technologies are widely used in neurosurgery, orthopedics, ENT procedures, and other clinical fields where monitoring neural function is essential for surgical safety.
In addition to sophisticated diagnostic systems, NCC manufactures a comprehensive range of medical consumables designed to support neuromonitoring and surgical procedures. These include electrodes, monitoring accessories, probes, and other specialized instruments that integrate seamlessly with modern medical equipment.
NCC’s global footprint continues to expand rapidly. Today, the company’s clinical technologies are used in more than 50 countries worldwide and in over 5,000 hospitals across China. From leading academic hospitals to regional medical centers, healthcare providers rely on NCC solutions to improve surgical precision and diagnostic efficiency.
A strong international distribution strategy forms an important part of NCC’s global growth. By collaborating with distributors and healthcare partners worldwide, NCC ensures that its technologies and medical consumables are accessible to healthcare professionals in diverse medical environments.
To further support clinicians and biomedical engineers, NCC has established 31 training and technical support centers across China. These centers provide comprehensive clinical training, technical support, and continuing professional education programs. Through the NCC Innovation Academy and the NeuGuard Service Platform, the company promotes knowledge sharing and supports the effective implementation of advanced neuromonitoring technologies.
Guided by the mission “Safeguarding Life and Health,” NCC continues to invest in innovation, quality improvement, and international collaboration. The company remains committed to advancing safer surgeries, enabling more precise diagnostics, and supporting healthcare professionals worldwide with reliable medical technologies.
Copyright © NCC Medical Co., Ltd. - Privacy policy